Lawsuit Filed against KT&G Directors for Alleged Losses

Regulations by 2FIRSTS.ai
Jan.23.2024
Lawsuit Filed against KT&G Directors for Alleged Losses
KT&G faces a lawsuit from activist fund, Flashlight Capital Partners, alleging current and former directors caused billions in losses.

According to South Korean media outlet Newssis, current and former directors of KT&G, a South Korean tobacco company, have been sued by activist fund Flashlight Capital Partners (FCP). It is alleged that their actions have resulted in the company incurring a loss of over 1 trillion Korean won (748 million US dollars).

 

KT&G’s position is that the contribution of treasury stocks is a legitimate procedure for the company's social contribution activities and employee welfare. Earlier, FCP sent a request to the Chairman of KT&G's Audit Committee to file a director's liability lawsuit, the contents of which are as follows. The investigation targets 21 former and current internal and external directors, including the current KT&G President, Baek Bok-in. If KT&G does not file a lawsuit against the directors within 30 days of receiving the request, FCP can initiate a shareholder representative lawsuit. FCP claims that since 2001, Baek Bok-in and other members of the board of directors have donated 10 million KT&G treasury stocks to foundations and funds, rather than increasing shareholder value through cancellation and sale, causing damage to the company. In response, KT&G stated in a statement, "In order to fulfill corporate social responsibility, the company donated a portion of treasury stocks for the improvement of public welfare and employee benefits.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
The EU’s consultation on the Cardiovascular Health Plan, though not mentioning nicotine, has sparked debate over novel tobacco regulation. Advocates urge evidence-based recognition of harm reduction products, while opponents call for tighter rules. The plan may influence TPD III, drawing close scrutiny from both industry and health groups.
Sep.01
2Firsts to Host Special Session at InterTabac on September 19
2Firsts to Host Special Session at InterTabac on September 19
2Firsts will host a special session at the InterTabac exhibition in Dortmund on September 19, 2025, under the theme “From Change to Opportunity.” As an official media partner, 2Firsts will highlight technology, supply chain, market, and capital opportunities while fostering global dialogue.
Sep.15
Malaysia’s Perlis and Terengganu Ban Vape Sales Starting August; Violators May Face Forced Closure
Malaysia’s Perlis and Terengganu Ban Vape Sales Starting August; Violators May Face Forced Closure
As of August 1, Perlis and Terengganu have enforced vape sales bans. Retailers violating the ban face immediate closure, with non-compliance leading to forced shutdowns. The move follows Islamic law rulings and aligns both states with Johor and Kelantan.
Aug.01 by 2FIRSTS.ai
Company | Philip Morris CEO: Expected profit growth in 2025 will be the highest in over a decade, with ZYN US retail sales up 32%
Company | Philip Morris CEO: Expected profit growth in 2025 will be the highest in over a decade, with ZYN US retail sales up 32%
At the 2025 Barclays Global Consumer Conference, Philip Morris International's CEO said that strong summer sales of IQOS and ZYN will boost the company's full-year 2025 adjusted EPS by 13% to 15%, the best performance since 2011 (excluding pandemic recovery). He also noted that IQOS has maintained strong growth in Q3, with ZYN sales up about 32% in the first eight weeks. The full-year shipment volume is expected to be between 800 million and 840 million cans.
Sep.03 by 2FIRSTS.ai
Singapore PM: E-Cigarettes to Be Treated as a Drug Issue, With Tougher Penalties and Whole-of-Government Enforcement
Singapore PM: E-Cigarettes to Be Treated as a Drug Issue, With Tougher Penalties and Whole-of-Government Enforcement
Singapore Prime Minister Lawrence Wong has announced that the government will begin treating e-cigarettes as a “drug problem,” strengthening enforcement and imposing harsher penalties, including imprisonment, on those who sell e-cigarettes containing harmful substances. At the same time, a nationwide public education campaign will be launched.
Aug.18 by 2FIRSTS.ai
Observation | As China’s Nicotine Pouch Supply Chain Cools, Market Focus Accelerates Abroad
Observation | As China’s Nicotine Pouch Supply Chain Cools, Market Focus Accelerates Abroad
China’s nicotine pouch sector saw a sharp decline in exhibitors and traffic. Insiders cite tighter regulation and rising overseas competition, with many firms turning to Europe, the U.S., and the Middle East, and some building factories in Indonesia for growth.
Aug.28 by 2FIRSTS.ai